Aquestive Therapeutics (AQST) CEO Barber sells $2400 in stock
NegativeFinancial Markets

In a recent development, the CEO of Aquestive Therapeutics, Barber, sold $2400 worth of stock, raising concerns among investors about the company's future. Such insider selling can often signal a lack of confidence in the company's performance, which may lead to a decline in stock value and investor trust. This move is particularly noteworthy as it comes at a time when the company is navigating challenges in the market.
— Curated by the World Pulse Now AI Editorial System